Ameriprise’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Ameriprise’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-16,096	Closed	-$738K	–	4159
2015 Q1	$738K	Sell	16,096 -24,866	-61%	-$744K	﹤0.01%	3064
2014 Q4	$983K	Sell	40,962 -30	-0.1%	-$676	﹤0.01%	2891
2014 Q3	$1.03M	Sell	40,992 -420	-1%	-$10.4K	﹤0.01%	2786
2014 Q2	$1.08M	Sell	41,412 -630	-1%	-$16.2K	﹤0.01%	2754
2014 Q1	$1.08M	Buy	42,042 +10,000	+31%	+$271K	﹤0.01%	2694
2013 Q4	$648K	Buy	32,042 +24,569	+329%	+$578K	﹤0.01%	2785
2013 Q3	$196K	Sell	7,473 -400	-5%	-$10K	﹤0.01%	3192
2013 Q2	$174K	Buy	+7,873	New	+$172K	﹤0.01%	3142

Ameriprise's HPTX Position: Q2 2015 in Review

Ameriprise sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 16,096 shares — an estimated $738K sold.

Ameriprise first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $1.08M in Q1 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Ameriprise reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Ameriprise sold 16,096 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $738K.
Ameriprise first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
Ameriprise's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.08M in Q1 2014.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Ameriprise's 13F filing for Q2 2015, filed 13 Aug 2015.